We are live on ! Find out more
TGTX icon

TG Therapeutics
TGTX

81 hedge funds and large institutions have $250M invested in TG Therapeutics in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 35 increasing their positions, 20 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 87 → 81 (-6)

22% less capital invested

Capital invested by funds: $320M → $250M (-$71M)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

73% less call options, than puts

Call options by funds: $338K | Put options by funds: $1.25M

Holders
81
Holders Change
-6
Holders Change %
-6.9%
% of All Funds
2.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
9
Increased
35
Reduced
20
Closed
15
Calls
$338K
Puts
$1.25M
Net Calls
-$910K
Net Calls Change
+$170K

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$15M
2
VAM
Visium Asset Management
New York
+$4.59M
3
UBS AM
UBS AM
Illinois
+$4.08M
4
BM
Bridger Management
New York
+$2.43M
5
TRSOTSOK
Teachers Retirement System of the State of Kentucky
Kentucky
+$1.41M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.07M
2
Millennium Management
Millennium Management
New York
-$1.89M
3
CCI
Columbus Circle Investors
-$811K
4
UBS Group
UBS Group
Switzerland
-$554K
5
OAM
Oxford Asset Management
United Kingdom
-$443K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$962K – – –
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$684K +$129K +14,762 +23%
Morgan Stanley
28
Morgan Stanley
New York
$610K +$220K +25,107 +54%
FAM
29
Fred Alger Management
New York
$580K -$108K -12,350 -15%
Charles Schwab
30
Charles Schwab
California
$504K – – –
Swiss National Bank
31
Swiss National Bank
Switzerland
$466K +$97.1K +11,100 +24%
Deutsche Bank
32
Deutsche Bank
Germany
$460K -$27.1K -3,102 -5%
TA
33
Teachers Advisors
New York
$457K – – –
WMSA
34
Weiss Multi-Strategy Advisers
New York
$435K – – –
AllianceBernstein
35
AllianceBernstein
Tennessee
$390K -$99.8K -11,400 -20%
CS
36
Credit Suisse
Switzerland
$340K +$41.2K +4,704 +13%
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$293K +$350 +40 +0.1%
HT
38
HAP Trading
New York
$286K -$27.5K -3,141 -9%
Creative Planning
39
Creative Planning
Kansas
$274K -$46.4K -5,301 -14%
Citigroup
40
Citigroup
New York
$249K +$224K +25,590 +695%
MLICM
41
Metropolitan Life Insurance Company (MetLife)
New York
$217K – – –
Parallax Volatility Advisers
42
Parallax Volatility Advisers
California
$213K +$50.8K +5,803 +30%
NFA
43
Nationwide Fund Advisors
Ohio
$207K -$10.2K -1,170 -5%
VEA
44
Virtus ETF Advisers
New York
$204K +$210K +23,986 New
Manulife (Manufacturers Life Insurance)
45
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$203K +$1.96K +224 +1%
AIG
46
American International Group
New York
$190K – – –
Wells Fargo
47
Wells Fargo
California
$178K -$2.95K -337 -2%
EMG
48
Ellington Management Group
Connecticut
$165K +$79.2K +9,051 +87%
Mariner
49
Mariner
Kansas
$156K +$2.23K +255 +1%
BG
50
BlackRock Group
United Kingdom
$149K +$92.2K +10,542 +153%
1
2
3 4

TGTX Hedge Fund Activity: Q1 2016 in Review

81 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TG Therapeutics (TGTX) for Q1 2016, worth a combined $250M — down 22% from $320M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of TGTX and 9 opened new positions — a net loss of 6 holders — while 20 trimmed existing stakes and 35 added.

The largest buyer was RA Capital Management, adding an estimated $15M. The largest seller was Fidelity Investments, cutting an estimated $2.07M.

  • 81 institutional investors held TG Therapeutics (TGTX) as of Q1 2016, down from 87 in Q4 2015.
  • Funds reported $250M of TG Therapeutics stock for Q1 2016, down 22% quarter-over-quarter.
  • 9 funds opened new TG Therapeutics positions in Q1 2016 and 15 closed out, a net change of -6 holders.
  • The largest TG Therapeutics buyer in Q1 2016 was RA Capital Management, an estimated $15M added.
  • The largest TG Therapeutics seller in Q1 2016 was Fidelity Investments, an estimated $2.07M sold.

Based on aggregated 13F filings for Q1 2016.